Bei Akademie registrieren
Amgen, US0311621009

Amgen stock at EUR 410.53, down 1.82% before Xetra

Published on 11/06/2026 at 08:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Amgen's latest reporting cycle included higher 2026 revenue and adjusted EPS ranges. The reference base is the Xetra close of November 5, 2026 at EUR 418.15.

Amgen outlook supports investor focus

  • Amgen recently raised its 2026 revenue and adjusted EPS ranges.
  • Third-quarter revenue rose 8 percent to USD 10.4 billion.
  • The outlook update remains the key company-specific factor for investors.
Amgen, US0311621009, Illustration mit AI erstellt.
Amgen, US0311621009, Illustration mit AI erstellt.

Amgen stock traded at EUR 410.53 on Lang & Schwarz at 08:44 CET on Friday, November 6, 2026, 1.82 percent below the Xetra close of Thursday, November 5, 2026 at EUR 418.15.

Amgen recently raised its 2026 revenue and adjusted EPS ranges, according to the company's latest reporting update. Third-quarter revenue rose 8 percent to USD 10.4 billion, keeping the revised full-year outlook at the center of investor attention.

Investors can follow the real-time quote of Amgen stock during the session.

The broader US equity market remains the main reference for sector sentiment; investors can follow S&P 500 market coverage.

More news and analyses on Amgen stock are available in the company topic.

Disclaimer...
en | US0311621009 | AMGEN | boerse | 70468313 |